PRIMARY STUDY

The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder

Key Findings:  This observational study of children with Autism Spectrum Disorder (ASD) aimed to detect lipid metabolites in saliva to be able to assess cannabis responsiveness and allow for quantification of future studies on the efficacy of medical cannabis in treating patients with ASD.